Neothetics IPO Info
Company Name: Neothetics
Stock Symbol: NEOT
Exchange: NASDAQ
Status: Priced
IPO Date: 11/20/2014
IPO Price:
14.00 (
-46.57%)
Underwriters
Piper Jaffray & Co. and Guggenheim Securities, LLC
Amount of Offering: N/A
Number of Shares Offered: 4.3 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Neothetics is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The lead product candidate, LIPO-202, is for the reduction of subcutaneous fat in the central abdomen in non-obese patients, an indication for which there is no FDA-approved drug. If approved, LIPO-202 may be a best-in-class non-surgical, non-ablative procedure and first-in-class injectable formulation for localized fat reduction and body contouring.
News Headlines
